MIRECC / CoE
Elaine R. Peskind, M.D., Co-Director | NW MIRECC
Elaine R. Peskind, M.D.
Elaine Peskind, MD, is Co-Director of the VA VISN 20 Northwest Network Mental Illness Research, Education, and Clinical Center (MIRECC). She is also the Friends of Alzheimer’s Research Professor of Psychiatry and Behavioral Sciences at the University of Washington (UW) School of Medicine.
Dr. Elaine Peskind's research over the past 35 years has addressed brain stress hormone systems in aging and Alzheimer’s disease, treatment of cognitive and behavioral problems in Alzheimer's Disease, and cerebrospinal fluid biomarkers in Alzheimer’s disease and related neurodegenerative dementing disorders. Dr. Peskind is Co-PI of a national multi-center study of prazosin for disruptive agitation in Alzheimer’s disease funded by the Alzheimer’s Disease Cooperative Study. More recently, Dr. Peskind’s research has focused on combat trauma posttraumatic stress disorder and the clinical phenomenology as well as neuroimaging and cerebrospinal fluid biomarkers of neurodegeneration in combat blast concussion mild traumatic brain injury and in Gulf War Veterans Illness.
Dr. Elaine Peskind continues to conduct single site as well as multi-site large-scale studies of cerebrospinal fluid biomarkers and pharmacological treatment trials for behavioral disorders and traumatic brain injury. Dr. Peskind has over 340 publications and has been continuously funded with Veterans Affairs Merit Review or NIH R01 grants for over 20 years; she is the PI of both the NIA T32 training grant: “Neurobehavior, Neuropathology, and Risk Factors in Alzheimer’s Disease,” and the Mental Illness Research, Education, and Clinical Center Advanced Research Fellowship.
Dr. Elaine Peskind is an elected Fellow of the American College of Neuropsychopharmacology. In 2018, Dr. Peskind was selected as the recipient of the Paul B. Magnuson Award, Veterans Affairs Rehabilitation Research and Development’s highest award for outstanding research in traumatic brain injury, PTSD, and neurodegenerative disorders.